1-2 of 2
Authors: Mark T Osterman
Save search
Sort by
Journal Article

Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension

PDF
Silvio Danese and others
Journal of Crohn's and Colitis, Volume 18, Issue 2, February 2024, Pages 264–274, https://doi.org/10.1093/ecco-jcc/jjad146
Published: 31 August 2023
Journal Article
EDITOR'S CHOICE

Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel Disease Get access

PDF
Konstantinos Papamichael and others
Journal of Crohn's and Colitis, Volume 12, Issue 7, July 2018, Pages 804–810, https://doi.org/10.1093/ecco-jcc/jjy039
Published: 24 March 2018